Applications of DL-3-(4-Fluorophenyl)Alanine in Industrial Manufacturing

DL-3-(4-Fluorophenyl)Alanine serves as a specialized chiral intermediate in demanding pharmaceutical, agrochemical, and fine chemical synthesis. Our facility supplies this material for critical downstream applications, supporting regulated manufacturing environments and precise formulation requirements.

1. Active Pharmaceutical Ingredient (API) Synthesis for Antipsychotic Compounds

DL-3-(4-Fluorophenyl)Alanine functions as a key building block in the manufacture of novel APIs targeting central nervous system disorders, particularly certain atypical antipsychotics. Customers incorporate this intermediate during the assembly of specific aryl substituted alanine derivatives, crucial for receptor affinity modulation in target compounds. Manufacturers optimize batch processes and purification steps under strict regulatory oversight, ensuring product traceability and impurity control from the chiral raw material stage forward.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) monographs related to amino acid derivatives
• FDA 21 CFR Part 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals)
• ISO 9001:2015 for chemical quality system management

Typical usage ratio

• Introduced at 1.2–1.5 molar equivalents relative to aryl halide precursors; adjusted based on required enantiomeric excess and downstream purification yield

Downstream process integration

• Used at the chiral coupling step to introduce the fluorophenyl moiety before key cyclization or amidation reactions
• Feeds directly into hydrogenation and protection/deprotection sequences
• Integrated within multi-step synthesis for control of stereochemistry
• Subjected to monitoring by HPLC and NMR through each processing stage

Final product types

• Pharmaceutical grade antipsychotic tablets
• Injectable active ingredients for CNS therapies
• Oral suspensions containing fluorinated phenylalanine-derived APIs
• Solid dose forms for controlled-release mental health medications

2. Synthesis of Peptidomimetic Drug Candidates

This compound plays an integral role in the assembly of synthetic peptide analogs for pharmaceutical R&D. Research facilities and contract development organizations use it as a non-natural amino acid component to enhance metabolic stability and receptor selectivity in bioactive peptides. Strict process control and analytical testing confirm incorporation fidelity and prevent racemization or unwanted isomer formation during solid-phase and solution-phase synthesis.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• U.S. Pharmacopeia (USP), General Chapter <1045> for amino acid analysis
• Good Laboratory Practice (GLP) for preclinical development
• OECD Guidelines for the Testing of Chemicals

Typical usage ratio

• 0.5–2 residues per peptide chain, tailored to target peptide sequence; usage determined by desired bioactivity profile and required structural modification

Downstream process integration

• Coupled via Fmoc/t-Boc-based peptide synthesis protocols
• Utilized at protected amino acid addition stage
• Subjected to orthogonal deprotection and HPLC purification
• Monitored by mass spectrometry for chain elongation verification

Final product types

• Investigational peptidomimetic API batches
• Lead candidates for peptide-based drug pipelines
• Modified linear and cyclic peptide analogs for clinical studies
• Specialty peptides used in receptor binding assays and pharmacological testing

3. Chiral Ligand Precursors in Asymmetric Catalysis

Processors use this fluorinated phenylalanine as a source of chirality in the preparation of ligands for metal-catalyzed enantioselective reactions. Synthetic chemists incorporate the compound during the formation of bidentate coordinate complexes, targeting fine chemical production routes where strict enantiocontrol directly impacts final product value. Facilities handling these processes operate under certified QA/QC systems, providing detailed batch documentation and analytical verification to downstream catalyst formulators and end-users.

Industry compliance standards

• ISO 17025 for laboratory analytical competence
• Responsible Care® management systems for chemical handling and safety
• REACH (EC 1907/2006) registration for downstream use in chemical synthesis
• Internal quality release specifications validated by NMR and elemental analysis

Typical usage ratio

• Used at 0.1–1.0 equiv. relative to metal centers, adjusted to achieve defined enantiomeric induction and catalyst loading per batch scale

Downstream process integration

• Condensed with bidentate scaffolds to construct chiral ligands prior to complexation
• Feeds into ligand derivatization, activation, and salt formation protocols
• Integrated into catalyst screening and scale-up runs for process development
• Subjected to optical purity testing before catalyst deployment

Final product types

• Chiral catalyst systems for asymmetric hydrogenation
• Ligand libraries for fine chemicals synthesis
• Custom catalyst kits for pharmaceutical intermediates manufacturing
• Laboratory analytical standards for chiral process validation

4. Fine Agrochemical Intermediate Production

Manufacturers specializing in crop protection and agrochemical actives deploy DL-3-(4-Fluorophenyl)Alanine as a precursor during the synthesis of certain phenylalanine-derived herbicide scaffolds. Agrochemical production lines require rigorous source tracing and impurity control at every synthetic step. Our plants deliver precise material specifications and lot documentation to satisfy plant protection product authorization and downstream stewardship demands.

Industry compliance standards

• FAO Specifications for Plant Protection Products
• ISO 9001:2015 for agrochemical manufacturing
• EN 16523 for impurity profiling of active ingredients
• REACH (EU chemicals safety and reporting requirements)

Typical usage ratio

• Formulated at 3–8% mass ratio in key coupling steps; adjusted according to targeted conversion rates and downstream process efficiency

Downstream process integration

• Introduced as a nucleophilic partner in aromatic substitution or amidation protocols
• Feeds into coupling reaction preceding active ingredient ring closure
• Follows strict batch release testing for pesticide registration compliance
• Subjected to LC/MS for trace contaminant confirmation

Final product types

• Phenylalanine-derived herbicide technical concentrates
• Pre-emergence weed control actives
• EPA-registered plant protection chemicals
• Formulated crop treatment intermediates for custom blends

5. Synthesis of Specialty Fine Chemicals for Research Reagents

Academic and industrial research labs purchase DL-3-(4-Fluorophenyl)Alanine for small molecule library assembly and custom reagent production. The material offers structural features attractive to medicinal, organic, and analytical chemistry programs requiring specific aromatic substitution patterns. QC laboratories demand batch-to-batch consistency, supplied under audit-ready management systems with full analytical documentation for traceability and data integrity in research-driven workflows.

Industry compliance standards

• ISO 9001:2015 for analytical chemical supply
• Good Laboratory Practice (GLP) for research chemical registration
• OECD Principles of Good Laboratory Practice
• Sigma-Aldrich research chemical grade acceptance criteria

Typical usage ratio

• Applied at 0.1–10 mmol scale depending on synthesis route and compound library depth; actual charges set per reaction design and inventory protocol

Downstream process integration

• Utilized as starting material in multi-step custom organic synthesis
• Fed into formation of labeled standards for analytical method development
• Basis for derivatization in assay calibration prep
• Stocked as a building block in compound screening panels

Final product types

• Research-use-only reagent kits
• Reference standards for trace analytical quantification
• Non-clinical chemical libraries for assay development
• Specialty fluorinated analogs for mechanistic studies